Skip to main content

Loading market data...

MEDP

Medpace Holdings, Inc.

NASDAQ • United states

$662.48

+$40.05

(+6.43%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Medpace Holdings, Inc. (MEDP)

Unavailable

Quotes may be delayed

$18.49B

Market Cap

912,813

Volume

37.6

P/E Ratio

Unavailable

Div Yield

Medpace Holdings, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 5375 MEDPACE WAY, CINCINNATI, OH
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Medpace Holdings, Inc. reported Operating or financial results

Medpace Holdings, Inc. filed an 8-K covering operating or financial results, another company event, supporting financial statements or exhibits.

29 Sep 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Medpace Holdings, Inc..

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Medpace Holdings, Inc..

24 Jul 2026

Medpace Holdings, Inc. filed Form 10-Q

Medpace Holdings, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

23 Jul 2026

Medpace Holdings, Inc. reported Operating or financial results

Medpace Holdings, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$502.69M

Total assets (USD)$2.06B

Total liabilities (USD)$1.62B

Shareholders' equity (USD)$433.86M

Long-term debt (USD)$0

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$707.33M	$146.82M	$121.36M	$4.25	10-Q · 23 Jul 2026
Q1 2026	$706.60M	$141.50M	$123.87M	$4.28	10-Q · 23 Apr 2026
Q4 2025	$708.45M	$153.27M	$135.13M	Unavailable	10-K · 10 Feb 2026
Q3 2025	$659.90M	$141.81M	$111.14M	$3.86	10-Q · 23 Oct 2025
Q2 2025	$603.31M	$126.34M	$90.26M	$3.10	10-Q · 22 Jul 2025
Q1 2025	$558.57M	$113.52M	$114.60M	$3.67	10-Q · 22 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $612.10

-7.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

2

⏸️

Hold

10

📉

Sell

0

12 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 20:50 UTC Targets range 492.00–700.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

12

Oct 2026

BURWIG SUSAN E

Exec. VP, Operations

Option exercise

$166.73 per share

3,000 shares

7

Oct 2026

BURWIG SUSAN E

Exec. VP, Operations

Option exercise

$166.73 per share

2,000 shares

30

Sep 2026

McCarthy Cornelius P. III

Director

Option exercise

Unavailable per share

28 shares

30

Sep 2026

Kraft Robert O.

Director

Option exercise

Unavailable per share

32 shares

30

Sep 2026

Carley Brian T

Director

Option exercise

Unavailable per share

36 shares

30

Sep 2026

Troendle August J.

Director, President & CEO, 10% owner

Open-market sale

$625.47 per share

21,966 shares

29

Sep 2026

Troendle August J.

Director, President & CEO, 10% owner

Open-market sale

$621.02 per share

26,701 shares

28

Sep 2026

Troendle August J.

Director, President & CEO, 10% owner

Open-market sale

$620.07 per share

2,410 shares

25

Sep 2026

Troendle August J.

Director, President & CEO, 10% owner

Open-market sale

$620.60 per share

154 shares

24

Sep 2026

Troendle August J.

Director, President & CEO, 10% owner

Open-market sale

$621.33 per share

27,833 shares

Top Shareholders

Blackrock, Inc.

2,498,248 shares

1.126% change

6/30/2026

Vanguard Group Inc

2,261,848 shares

-0.925% change

12/31/2025

Price T Rowe Associates Inc /Md/

2,069,677 shares

614.897% change

6/30/2026

Aqr Capital Management Llc

1,278,935 shares

-5.533% change

6/30/2026

Vanguard Portfolio Management Llc

1,133,357 shares

1.04% change

6/30/2026

Vanguard Capital Management Llc

1,026,820 shares

1.558% change

6/30/2026

State Street Corp

710,895 shares

4.202% change

6/30/2026

Geode Capital Management, Llc

710,465 shares

-4.649% change

6/30/2026

Invesco Ltd.

579,241 shares

0.289% change

6/30/2026

Baillie Gifford & Co

473,211 shares

-5.958% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 20:50 UTC· 12 hours ago

Research coverage and investment tools

Medpace Holdings, Inc. (MEDP) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch). Its last price was US$662.48 on 21 Oct 2026. That is 95% of the way from its 52-week low of US$373.00 to its 52-week high of US$677.90. Its market capitalisation was US$18.49 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$707.33M	$146.82M	$121.36M	$4.25	—	20.8%	$138.10M	10-Q · 23 Jul 2026 (opens in a new tab)
Q1 2026	$706.60M	$141.50M	$123.87M	$4.28	—	20.0%	$144.97M	10-Q · 23 Apr 2026 (opens in a new tab)
Q4 2025	$708.45M	$153.27M	$135.13M	Unavailable	—	21.6%	$188.12M	10-K · 10 Feb 2026 (opens in a new tab)
Q3 2025	$659.90M	$141.81M	$111.14M	$3.86	—	21.5%	$235.50M	10-Q · 23 Oct 2025 (opens in a new tab)
Q2 2025	$603.31M	$126.34M	$90.26M	$3.10	—	20.9%	$142.41M	10-Q · 22 Jul 2025 (opens in a new tab)
Q1 2025	$558.57M	$113.52M	$114.60M	$3.67	—	20.3%	$115.84M	10-Q · 22 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/22/2026	$4.25	$4.08	+4.2%
Mar 2026	4/22/2026	$4.28	$3.74	+14.4%
Dec 2025	2/9/2026	$4.67	$4.18	+11.7%
Sep 2025	10/22/2025	$3.86	$3.50	+10.3%

Cash and equivalents: $502.69M
Total assets: $2.06B
Total liabilities: $1.62B
Shareholders' equity: $433.86M
Long-term debt: $0
Debt due within a year: $0

8-K · 21 Oct 2026

Medpace Holdings, Inc. reported Operating or financial results (opens in a new tab)

Medpace Holdings, Inc. filed an 8-K covering operating or financial results, another company event, supporting financial statements or exhibits.
SCHEDULE 13D/A · 29 Sep 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Medpace Holdings, Inc..
SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Medpace Holdings, Inc..
10-Q · 24 Jul 2026

Medpace Holdings, Inc. filed Form 10-Q (opens in a new tab)

Medpace Holdings, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 23 Jul 2026

Medpace Holdings, Inc. reported Operating or financial results (opens in a new tab)

Medpace Holdings, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
BURWIG SUSAN E Exec. VP, Operations	12 Oct 2026	Option exercise (M)	+3,000	$166.73	Form 4 (opens in a new tab)
BURWIG SUSAN E Exec. VP, Operations	7 Oct 2026	Option exercise (M)	+2,000	$166.73	Form 4 (opens in a new tab)
McCarthy Cornelius P. III Director	30 Sep 2026	Option exercise (M)	+28	—	Form 4 (opens in a new tab)
Kraft Robert O. Director	30 Sep 2026	Option exercise (M)	+32	—	Form 4 (opens in a new tab)
Carley Brian T Director	30 Sep 2026	Option exercise (M)	+36	—	Form 4 (opens in a new tab)
Troendle August J. Director, President & CEO, 10% owner	30 Sep 2026	Open-market sale (S)	−21,966	$625.47	Form 4 (opens in a new tab)
Troendle August J. Director, President & CEO, 10% owner	29 Sep 2026	Open-market sale (S)	−26,701	$621.02	Form 4 (opens in a new tab)
Troendle August J. Director, President & CEO, 10% owner	28 Sep 2026	Open-market sale (S)	−2,410	$620.07	Form 4 (opens in a new tab)
Troendle August J. Director, President & CEO, 10% owner	25 Sep 2026	Open-market sale (S)	−154	$620.60	Form 4 (opens in a new tab)
Troendle August J. Director, President & CEO, 10% owner	24 Sep 2026	Open-market sale (S)	−27,833	$621.33	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	2,498,248	1.126%
Vanguard Group Inc	12/31/2025	2,261,848	-0.925%
Price T Rowe Associates Inc /Md/	6/30/2026	2,069,677	614.897%
Aqr Capital Management Llc	6/30/2026	1,278,935	-5.533%
Vanguard Portfolio Management Llc	6/30/2026	1,133,357	1.04%
Vanguard Capital Management Llc	6/30/2026	1,026,820	1.558%
State Street Corp	6/30/2026	710,895	4.202%
Geode Capital Management, Llc	6/30/2026	710,465	-4.649%
Invesco Ltd.	6/30/2026	579,241	0.289%
Baillie Gifford & Co	6/30/2026	473,211	-5.958%

Previous close: 622.43 USD
Day range: 614.98 – 666.34 USD
52-week range: 373.00 – 677.90 USD
Volume: 912,813
Market cap: $18.49B
Average volume: 233,284
P/E ratio: 37.6
EPS (FY 2025, diluted): 15.28 USD
Shares outstanding: 27.91M
Beta (5Y monthly): 1.12

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 13 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:10 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for MEDP yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.